HIỆU QUẢ CÔNG CỤ THEO DÕI ĐÁI THÁO ĐƯỜNG TỪ XA GIÚP CẢI THIỆN KIỂM SOÁT ĐƯỜNG HUYẾT Ở BỆNH NHÂN ĐÁI THÁO ĐƯỜNG TÍP 2 NGOẠI TRÚ: BÁO CÁO LOẠT CA

Abstract

Glycemic control is essential in managing type 2 diabetes (T2D) to reduce complications and improve quality of life. In middle-income countries, 43.2%–55.6% of patients still fail to achieve HbA1c levels below 7%, mainly due to limited healthcare access and poor treatment adherence. Remote monitoring and teleconsultation have emerged as potential strategies to enhance disease management. Objective: To evaluate the effectiveness of a remote diabetes management program delivered via the OneMedic platform in outpatients. Subjects and Methods: A case series involving five T2D outpatients at the University Medical Center Ho Chi Minh City was conducted. All participants underwent a 12-week intervention using the OneMedic program, which included biweekly remote monitoring and consultations with healthcare professionals. Data were collected pre- and post-intervention to assess its effectiveness. Results: Five male patients (average age: 39 years; average diabetes duration: 4.2 years) were being treated with a combination of 2-4 classes of oral hypoglycemic agents, with a baseline average HbA1c level of 9.1%. After 12 weeks, the average HbA1c decreased by 1.17%. Improvements was also observed in fasting blood glucose, triglycerides, LDL-C, body weight, and several aspects of quality of life. No serious adverse events or dropouts were reported. Conclusions: Remote diabetes monitoring and counseling via the OneMedic platform demonstrated potential in improving glycemic and lipid control, as well as enhancing quality of life in T2D outpatients. This preliminary study provides a foundation for future large-scale research.